A first-in-human study of AMG 780, an angiopoietin-1 and -2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors.
Afshin Dowlati
No relevant relationships to disclose
Gordana Vlahovic
No relevant relationships to disclose
Ronald B. Natale
No relevant relationships to disclose
Erik Rasmussen
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Indrajeet Singh
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Yuying C. Hwang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
John Rossi
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Michael B. Bass
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Gregory R. Friberg
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Cheryl Ann Pickett-Gies
Employment or Leadership Position - Amgen
Stock Ownership - Amgen